Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 14Leukemia 10Lymphoma 8Leukemia, Lymphocytic, Chronic, B-Cell 6Lymphoma, Mantle-Cell 5Leukemia, Biphenotypic, Acute 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Myelodysplastic Syndromes 4Blast Crisis 4Waldenstrom Macroglobulinemia 3Lymphoma, B-Cell, Marginal Zone 3Recurrence 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasm, Residual 2Myeloproliferative Disorders 2Lymphoma, Follicular 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Hairy Cell 2Leukemia, Erythroblastic, Acute 2Graft vs Host Disease 2Thrombocythemia, Essential 1Sezary Syndrome 1Primary Myelofibrosis 1Precancerous Conditions 1Polycythemia Vera 1Neoplasms, Plasma Cell 1Mycosis Fungoides 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1

Interventions

fludarabine phosphate 29Cyclophosphamide 18Mycophenolic Acid 17Whole-Body Irradiation 16Peripheral Blood Stem Cell Transplantation 16Cyclosporine 13Antilymphocyte Serum 9Tacrolimus 8Cyclosporins 8fludarabine 7Rituximab 7Busulfan 7Filgrastim 6Sirolimus 4Methotrexate 4Cytarabine 4Thiotepa 3Therapeutics 3Melphalan 3Lenalidomide 3Granulocyte Colony-Stimulating Factor 3Etoposide 3Epoetin Alfa 3Darbepoetin alfa 3Cord Blood Stem Cell Transplantation 3Carboplatin 3Allopurinol 3pegfilgrastim 2liposomal amphotericin B 2Radiotherapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, Prolymphocytic × Cladribine × Clear all
NCT00003746 2012-05-15

Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia

Swiss Cancer Institute

Phase 3 Completed
100 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Prolymphocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡